119 related articles for article (PubMed ID: 34706158)
1. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
[TBL] [Abstract][Full Text] [Related]
2. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
[TBL] [Abstract][Full Text] [Related]
4. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
[TBL] [Abstract][Full Text] [Related]
6. Frequent mutation of BAP1 in metastasizing uveal melanomas.
Harbour JW; Onken MD; Roberson ED; Duan S; Cao L; Worley LA; Council ML; Matatall KA; Helms C; Bowcock AM
Science; 2010 Dec; 330(6009):1410-3. PubMed ID: 21051595
[TBL] [Abstract][Full Text] [Related]
7. Long-Read Sequencing Reveals Alternative Splicing-Driven, Shared Immunogenic Neoepitopes Regardless of SF3B1 Status in Uveal Melanoma.
Yao T; Zhang Z; Li Q; Huang R; Hong Y; Li C; Zhang F; Huang Y; Fang Y; Cao Q; Jin X; Li C; Wang Z; Lin XJ; Li L; Wei W; Wang Z; Shen J
Cancer Immunol Res; 2023 Dec; 11(12):1671-1687. PubMed ID: 37756564
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma.
Djulbegovic MB; Taylor DJ; Uversky VN; Galor A; Shields CL; Karp CL
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292588
[TBL] [Abstract][Full Text] [Related]
9. GZ17-6.02 kills PDX isolates of uveal melanoma.
Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of driver events in metastatic uveal melanoma.
Karlsson J; Nilsson LM; Mitra S; Alsén S; Shelke GV; Sah VR; Forsberg EMV; Stierner U; All-Eriksson C; Einarsdottir B; Jespersen H; Ny L; Lindnér P; Larsson E; Olofsson Bagge R; Nilsson JA
Nat Commun; 2020 Apr; 11(1):1894. PubMed ID: 32313009
[TBL] [Abstract][Full Text] [Related]
11. BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas.
Kaler CJ; Dollar JJ; Cruz AM; Kuznetsoff JN; Sanchez MI; Decatur CL; Licht JD; Smalley KSM; Correa ZM; Kurtenbach S; Harbour JW
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954340
[TBL] [Abstract][Full Text] [Related]
12. Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition.
Potts KS; Cameron RC; Metidji A; Ghazale N; Wallace L; Leal-Cervantes AI; Palumbo R; Barajas JM; Gupta V; Aluri S; Pradhan K; Myers JA; McKinstry M; Bai X; Choudhary GS; Shastri A; Verma A; Obeng EA; Bowman TV
Cell Rep; 2022 Dec; 41(11):111825. PubMed ID: 36516770
[TBL] [Abstract][Full Text] [Related]
13. Dose-Dependent Carbon-Dot-Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism.
Ding Y; Yu J; Chen X; Wang S; Tu Z; Shen G; Wang H; Jia R; Ge S; Ruan J; Leong KW; Fan X
Adv Sci (Weinh); 2021 Apr; 8(8):2002404. PubMed ID: 33898168
[TBL] [Abstract][Full Text] [Related]
14. Pathological and Molecular Diagnosis of Uveal Melanoma.
Păsărică MA; Curcă PF; Dragosloveanu CDM; Grigorescu AC; Nisipașu CI
Diagnostics (Basel); 2024 May; 14(9):. PubMed ID: 38732371
[TBL] [Abstract][Full Text] [Related]
15. Correction to: BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Mar; 40(9):1753. PubMed ID: 33510355
[No Abstract] [Full Text] [Related]
16. Editor's Note: Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein.
Zhao B; Kim J; Ye X; Lai ZC; Guan KL
Cancer Res; 2021 Nov; 81(21):5583. PubMed ID: 34725135
[No Abstract] [Full Text] [Related]
17. BAP1 loss augments sensitivity to BET inhibitors in cancer cells.
Xu YY; Ren ZL; Liu XL; Zhang GM; Huang SS; Shi WH; Ye LX; Luo X; Liu SW; Li YL; Yu L
Acta Pharmacol Sin; 2022 Jul; 43(7):1803-1815. PubMed ID: 34737422
[TBL] [Abstract][Full Text] [Related]
18. Designer proteins that competitively inhibit Gα
Hussain M; Cummins MC; Endo-Streeter S; Sondek J; Kuhlman B
J Biol Chem; 2021 Dec; 297(6):101348. PubMed ID: 34715131
[TBL] [Abstract][Full Text] [Related]
19. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma.
Shoushtari AN; Khan S; Komatsubara K; Feun L; Acquavella N; Singh-Kandah S; Negri T; Nesson A; Abbate K; Cremers S; Musi E; Ambrosini G; Lee S; Schwartz GK; Carvajal RD
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771668
[TBL] [Abstract][Full Text] [Related]
20. Genetic Landscape and Emerging Therapies in Uveal Melanoma.
Seedor RS; Orloff M; Sato T
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
